Mycophenolate mofetil can be used as monotherapy late after liver transplantation

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jose Maria Moreno PlanasI Millán

Abstract

We report our experience with calcineurin inhibitor (CNI) withdrawal and MMF monotherapy in 50 adult liver transplant (OLT) recipients with CNI-related toxicity. Thirty-four patients had chronic renal dysfunction (CRD) associated with arterial hypertension, 11 had only CRD and other five patients had hypertension. The mean time between OLT and introduction of MMF was 81 months. After the introduction of MMF, CNI was progressively reduced and withdrawn if possible. At the end of the follow up (mean time: 18 months) CNI was withdrawn in 39 patients (78%), and there was a significant decrease from baseline in serum creatinine (1.81-1.49 mg/dL; p < 0.0001), BUN (76.6-52.8 mg/dL; p < 0.0001) and uric acid (9-7.5 mg/dL; p < 0.0001) levels, and an increase in creatinine clearance (44.7-55.1 mL/min; p < 0.0001). Excluding patients who developed graft rejection and two patients who died, CRD improved in 32 of 40 patients (80%), and arterial hypertension improved in 22 of 29 patients (76%). Five patients (10%) developed acute rejection, and one patient (2%) chronic rejection. Twenty-six patients (52%) experienced side-effects, with asthenia, herpes virus infection, and diarrhea being the most common. Only eight patients (16%) required MM...Continue Reading

References

Jul 1, 1994·Cleveland Clinic Journal of Medicine·R M Graham
Jul 3, 1998·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·V J CanzanelloR A Krom
Jul 29, 1998·Transplantation·N C FisherJ M Neuberger
Sep 9, 1999·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·J I HerreroJ Prieto
Sep 18, 2001·Lancet·S F StewartC P Day
Dec 1, 2001·Transplantation·D A NealG J Alexander

❮ Previous
Next ❯

Citations

May 18, 2010·European Journal of Clinical Pharmacology·Zhang Wei XiaXie Jun Jie
Nov 16, 2005·Transplantation·Jochen KluppPeter Neuhaus
Jun 18, 2009·World Journal of Gastroenterology : WJG·Jing LiFu-Gui Li
Jul 26, 2014·Gastroenterología y hepatología·Lluís CastellsFederico Oppenheimer
Nov 26, 2015·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Maria ShipkovaEberhard Wieland
Jul 31, 2012·Transplantation Proceedings·M DemirayN O Barisik
Apr 5, 2011·Gastroenterología y hepatología·M Trinidad Serrano AullóSara Lorente Pérez
Apr 2, 2011·Transplantation Reviews·Marcelo CantarovichJ Michael Tredger
Apr 26, 2011·Transplantation Reviews·Fabrizio Sansone, Mauro Rinaldi
Dec 13, 2006·International Immunopharmacology·Itxarone BilbaoCarlos Margarit
Mar 6, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S DharancyF R Pruvot
Nov 15, 2006·Clinical Transplantation·Maximilian SchmedingPeter Neuhaus
Jul 29, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·François Durand
Feb 28, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Susanne BeckebaumIyad Kabar
Feb 8, 2011·Transplant International : Official Journal of the European Society for Organ Transplantation·Tommaso Maria ManziaGiuseppe Tisone
Oct 20, 2011·Clinical Transplantation·Michael KrissJosh Levitsky
Jul 13, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Fuat H SanerSusanne Beckebaum
Sep 26, 2015·Gastroenterología y hepatología·Fernando PardoUNKNOWN en nombre de la Sociedad Española de Trasplante Hepático
Sep 27, 2005·Transplantation Proceedings·A PieriniM Salizzoni
Sep 27, 2005·Transplantation Proceedings·T M ManziaG Tisone
Jul 26, 2005·Critical Reviews in Oncology/hematology·Anna L TaylorJ Andrew Bradley
Dec 15, 2010·Journal of Hepatology·C Duvoux, G P Pageaux
Jun 13, 2018·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·José Ignacio HerreroGloria Sánchez
Dec 13, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Giuseppe OrlandoGiuseppe Tisone
Jul 1, 2005·Expert Review of Clinical Immunology·Hans W Sollinger
Jul 22, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Philip M Ginsburg, Paul J Thuluvath
Jan 9, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Dirk R J KuypersUNKNOWN Transplantation Society (TTS) Consensus Group on TDM of MPA
Aug 26, 2014·World Journal of Gastroenterology : WJG·Hao Chen, Bing Chen
Aug 11, 2020·World Journal of Gastroenterology : WJG·Tian ShenXiao Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.